Reinilde Heyrman
Technik-/Wissenschafts-/F&E-Leiter bei MEDPACE HOLDINGS, INC.
Aktive Positionen von Reinilde Heyrman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MEDPACE HOLDINGS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2017 | - |
Karriereverlauf von Reinilde Heyrman
Ehemalige bekannte Positionen von Reinilde Heyrman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IKARIA, INC. | Corporate Officer/Principal | 01.01.2012 | - |
| BELLEROPHON THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2014 | - |
| Unternehmenssekretär | 01.02.2014 | - |
Ausbildung von Reinilde Heyrman
| University of Antwerp | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Belgien | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Secretary | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| MEDPACE HOLDINGS, INC. | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
- Börse
- Insiders
- Reinilde Heyrman
- Erfahrung
